U.S. Biotechnology Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Biotechnology
Cyclacel Pharmaceuticals Inc (CYCC) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial Waters and Advancing Clinical Trials
Insights into CYCC's financial health and strategic advancements in oncology research during the first quarter of 2024. 44 minutes ago
GuruFocus Research Biotechnology
Arcutis Biotherapeutics Inc (ARQT) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic Advances Amid Challenges
Explore key financial outcomes, product launches, and strategic initiatives as Arcutis Biotherapeutics navigates through a dynamic market landscape. 3 hours ago
GuruFocus Research Biotechnology
TRACON Pharmaceuticals Inc (TCON) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances Amid Financial Challenges
Explore key insights from TRACON Pharmaceuticals' Q1 2024 earnings, focusing on financial improvements, trial progress, and strategic maneuvers to maintain NASDAQ compliance. 3 hours ago
GuruFocus Research Biotechnology
scPharmaceuticals Inc (SCPH) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and Expanding Opportunities
Despite a net loss and increased operational costs, scPharmaceuticals Inc (SCPH) reports significant progress in product development and market expansion. 3 hours ago
GuruFocus Research Biotechnology
BioStem Technologies Inc (BSEM) Q1 2024 Earnings Call Transcript Highlights: A Remarkable Turnaround with Record Revenues and Profits
Discover how BioStem Technologies achieved a significant revenue increase and reported its first positive net income in Q1 2024. 3 hours ago
GuruFocus Research Biotechnology
MiNK Therapeutics Inc (INKT) Q1 2024 Earnings Call Transcript Highlights: Strategic Reductions and Promising Investments
Discover how MiNK Therapeutics Inc navigates financial challenges and advances key clinical programs amidst strategic operational adjustments. 3 hours ago
GuruFocus Research Biotechnology
Syros Pharmaceuticals Inc (SYRS) (Q1 2024) Earnings Call Transcript Highlights: Strategic Developments and Financial Insights
Explore key updates on clinical trials, financial shifts, and strategic insights from Syros Pharmaceuticals' Q1 2024 earnings call. 3 hours ago
GuruFocus Research Biotechnology
Acumen Pharmaceuticals Inc (ABOS) (Q1 2024) Earnings Call Transcript Highlights: Strategic Advances Amid Financial Challenges
Explore key insights from Acumen Pharmaceuticals' Q1 2024 earnings, focusing on their innovative Alzheimer's treatments and financial outlook. 3 hours ago